Vesselina COOKE

Person

Cambridge, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Protein kinase C inhibitors for treatment of uveal melanoma
- Patent number 12,208,097
- Issue date Jan 28, 2025
- Novartis AG
- Vesselina Cooke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy
- Patent number 12,036,227
- Issue date Jul 16, 2024
- Novartis AG
- Vesselina Cooke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic combinations comprising a c-RAF inhibitor
- Patent number 12,011,449
- Issue date Jun 18, 2024
- Novartis AG
- Giordano Caponigro
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Protein kinase C inhibitors for treatment of uveal melanoma
- Patent number 11,413,284
- Issue date Aug 16, 2022
- Novartis AG
- Vesselina Cooke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy
- Patent number 11,266,653
- Issue date Mar 8, 2022
- Novartis AG
- Vesselina Cooke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic uses of a C-RAF inhibitor
- Patent number 10,973,829
- Issue date Apr 13, 2021
- Novartis AG
- Giordano Caponigro
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Androgen receptor mutation
- Patent number 10,011,874
- Issue date Jul 3, 2018
- Novartis AG
- Giordano Caponigro
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
THERAPEUTIC COMBINATIONS COMPRISING A CRAF INHIBITOR
- Publication number 20240000789
- Publication date Jan 4, 2024
- Novartis AG
- Giordano Caponigro
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF A RAF INHIBITOR AND A MEK INHIBITOR FOR THE...
- Publication number 20230321110
- Publication date Oct 12, 2023
- Novartis AG
- Giordano CAPONIGRO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEIN KINASE C INHIBITORS FOR TREATMENT OF UVEAL MELANOMA
- Publication number 20220323436
- Publication date Oct 13, 2022
- NOVARTIS AG
- Vesselina COOKE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY
- Publication number 20220143036
- Publication date May 12, 2022
- Novartis AG
- Vesselina COOKE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC COMBINATIONS COMPRISING A C-RAF INHIBITOR
- Publication number 20220008426
- Publication date Jan 13, 2022
- Novartis AG
- Giordano CAPONIGRO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEIN KINASE C INHIBITORS FOR TREATMENT OF UVEAL MELANOMA
- Publication number 20200268749
- Publication date Aug 27, 2020
- Novartis AG
- Vesselina COOKE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY
- Publication number 20200246346
- Publication date Aug 6, 2020
- Novartis AG
- Vesselina COOKE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC USES OF A C-RAF INHIBITOR
- Publication number 20190175609
- Publication date Jun 13, 2019
- Novartis AG
- Giordano CAPONIGRO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL ANDROGEN RECEPTOR MUTATION
- Publication number 20160002727
- Publication date Jan 7, 2016
- Novartis AG
- Giordano CAPONIGRO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Vesselina COOKE

Person

Patents Grantslast 30 patents

Protein kinase C inhibitors for treatment of uveal melanoma

Combination therapy

Therapeutic combinations comprising a c-RAF inhibitor

Protein kinase C inhibitors for treatment of uveal melanoma

Combination therapy

Therapeutic uses of a C-RAF inhibitor

Androgen receptor mutation

Patents Applicationslast 30 patents

THERAPEUTIC COMBINATIONS COMPRISING A CRAF INHIBITOR

COMBINATION THERAPY OF A RAF INHIBITOR AND A MEK INHIBITOR FOR THE...

PROTEIN KINASE C INHIBITORS FOR TREATMENT OF UVEAL MELANOMA

COMBINATION THERAPY

THERAPEUTIC COMBINATIONS COMPRISING A C-RAF INHIBITOR

PROTEIN KINASE C INHIBITORS FOR TREATMENT OF UVEAL MELANOMA

COMBINATION THERAPY

THERAPEUTIC USES OF A C-RAF INHIBITOR

NOVEL ANDROGEN RECEPTOR MUTATION